Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $9.4 million.

  • iSpecimen's Liabilities and Shareholders Equity fell 20.12% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.2 million, marking a year-over-year decrease of 39.37%. This contributed to the annual value of $9.4 million for FY2024, which is 40.89% down from last year.
  • According to the latest figures from FY2024, iSpecimen's Liabilities and Shareholders Equity is $9.4 million, which was down 40.89% from $15.8 million recorded in FY2023.
  • In the past 5 years, iSpecimen's Liabilities and Shareholders Equity ranged from a high of $35.7 million in FY2021 and a low of $6.2 million during FY2020.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $15.8 million (2023), whereas its average is $16.6 million.
  • As far as peak fluctuations go, iSpecimen's Liabilities and Shareholders Equity soared by 475.22% in 2021, and later slumped by 40.89% in 2024.
  • Yearly analysis of 5 years shows iSpecimen's Liabilities and Shareholders Equity stood at $6.2 million in 2020, then surged by 475.22% to $35.7 million in 2021, then plummeted by 31.08% to $24.6 million in 2022, then tumbled by 35.74% to $15.8 million in 2023, then slumped by 40.89% to $9.4 million in 2024.